NASDAQ:OTRK - Nasdaq - US6833734014 - Common Stock - Currency: USD
1.592
-0.07 (-4.1%)
The current stock price of OTRK is 1.592 USD. In the past month the price decreased by -7.44%. In the past year, price decreased by -44.2%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CI | THE CIGNA GROUP | 10.97 | 82.08B | ||
CVS | CVS HEALTH CORP | 11.71 | 79.88B | ||
LH | LABCORP HOLDINGS INC | 17.15 | 20.84B | ||
DGX | QUEST DIAGNOSTICS INC | 19.1 | 19.12B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 13.74 | 13.55B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 148.77 | 12.18B | ||
DVA | DAVITA INC | 14.99 | 11.68B | ||
HIMS | HIMS & HERS HEALTH INC | 112 | 10.77B | ||
CHE | CHEMED CORP | 23.84 | 8.18B | ||
CRVL | CORVEL CORP | 25.97 | 5.57B | ||
OPCH | OPTION CARE HEALTH INC | 26.89 | 5.45B | ||
GH | GUARDANT HEALTH INC | N/A | 5.30B |
Ontrak Inc is a US-based company operating in Health Care Providers & Services industry. The company is headquartered in Miami, Florida and currently employs 102 full-time employees. The company went IPO on 2002-09-27. Ontrak, Inc. is an artificial intelligence (AI) and telehealth-enabled healthcare company. The firm identifies, engages, activates, and provides care pathways to treatment for the most vulnerable members of the behavioral health population who would otherwise fall through the cracks of the healthcare system. The company engages individuals with anxiety, depression, substance-use disorders and chronic disease through personalized care coaching and customized care pathways that help them receive the treatment and advocacy they need, despite the socio-economic, medical and health system barriers that exacerbate the severity of their comorbid illnesses. Its technology-enabled platform utilizes claim-based analytics and predictive modeling to provide analytic insights throughout the delivery of its personalized care program. The firm integrates evidence-based psychosocial and medical interventions delivered either in-person or via telehealth, along with care coaches.
ONTRAK INC
333 S. E. 2Nd Avenue, Suite 2000
Miami FLORIDA 90404 US
CEO: Terren S. Peizer
Employees: 103
Company Website: https://ontrakhealth.com/
Investor Relations: http://ontrakhealth.com/investors/
Phone: 13104444300
The current stock price of OTRK is 1.592 USD. The price decreased by -4.1% in the last trading session.
The exchange symbol of ONTRAK INC is OTRK and it is listed on the Nasdaq exchange.
OTRK stock is listed on the Nasdaq exchange.
7 analysts have analysed OTRK and the average price target is 4.08 USD. This implies a price increase of 156.28% is expected in the next year compared to the current price of 1.592. Check the ONTRAK INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ONTRAK INC (OTRK) has a market capitalization of 6.72M USD. This makes OTRK a Nano Cap stock.
ONTRAK INC (OTRK) currently has 103 employees.
ONTRAK INC (OTRK) has a support level at 1.43 and a resistance level at 1.66. Check the full technical report for a detailed analysis of OTRK support and resistance levels.
The Revenue of ONTRAK INC (OTRK) is expected to decline by -18.59% in the next year. Check the estimates tab for more information on the OTRK EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
OTRK does not pay a dividend.
ONTRAK INC (OTRK) will report earnings on 2025-04-14, after the market close.
ONTRAK INC (OTRK) does not have a PE ratio as the earnings reported over the last twelve months were negative (-10.62).
The outstanding short interest for ONTRAK INC (OTRK) is 2.5% of its float. Check the ownership tab for more information on the OTRK short interest.
ChartMill assigns a fundamental rating of 2 / 10 to OTRK. OTRK has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months OTRK reported a non-GAAP Earnings per Share(EPS) of -10.62. The EPS decreased by -26.02% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -159.29% | ||
ROE | -311.45% | ||
Debt/Equity | 0.69 |
ChartMill assigns a Buy % Consensus number of 83% to OTRK. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 86.79% and a revenue growth -18.59% for OTRK